Using Technology to Power Pharma and Clinical Genomics with Mike Klein

Genomenon CEO, Mike Klein met with Mike Maddox, host of ASK, to talk about Genomenon’s use of innovative technology to connect medical professionals with the scientific evidence they need to treat rare diseases and cancers.

Read more

Latest Update to Mastermind – Search by Therapy

The Mastermind Genomic Search Engine now includes the ability to search the genomic literature by therapy. Professional Edition users can now query our comprehensive database of genomic evidence for over 180,000 drugs, therapies, and other interventions.

Read more

Genomenon is 2020 Company of the Year in Global Clinical Genomics Interpretation

Genomenon was named the 2020 Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan today. The distinguished award highlights the superiority of Mastermind as a pioneering and first-in-class genomic database and leading research tool accelerating precision medicine. Below is the report in its entirety.

Read more

AI-Driven Literature Curation for Determining Genomic Variant Pathogenicity

Mark Kiel, Founder and Chief Science Officer of Genomenon was a featured presenter for the LabRoots Virtual Genetics & Genomics Event on May 8th and 9th, 2019. This is the transcript, slides and video from his talk, which opened the event on Thursday, May 9th.

Read more

Genomenon Honored as one of 50 Companies to Watch 2019

Mike Klein, CEO of Genomenon, as interviewed by Jeffrey Mosher, Operations Director of Michigan Business Network on Genomenon’s recent award as one of the Top 50 Companies to Watch in Michigan.

Read more

Don’t Call It a Comeback

Mark Kiel, Founder and Chief Science Officer of Genomenon, shares his comeback story at Startup Story Night 2019 at the Marble Bar in Detroit. Genomenon has come a very long way. Like any good story, we had our ups and downs, moments of excitement and fear while rapidly growing in a developing industry. Read about …

Read more